Asia-Pacific

Rapt licenses FLX-475 to Hanmi in deal worth up to $118M

December 10, 2019

HONG KONG – Rapt Therapeutics Inc., of San Francisco, and Seoul, South Korea-based Hanmi Pharmaceutical Co. Ltd. entered a license agreement for Rapt’s FLX-475 in Asia. FLX-475 is an oral, small-molecule CCR4 antagonist for cancer treatment.

Celltrion’s Remsima SC wins marketing approval in EU

December 3, 2019

By Jihyun Kim

No Comments

HONG KONG – Celltrion Healthcare Co. Ltd., a South Korean biopharmaceutical corporation, won European Union (EU) marketing approval for Remsima SC for the treatment of rheumatoid arthritis (RA), as a subcutaneous version of Celltrion’s infliximab biosimilar, CT-P13.

Indian pharma sector needs to learn from its competitors: report

December 3, 2019

By T.V. Padma

No Comments

NEW DELHI, India – While India is still an attractive prospect for investment in biotechnology, the country needs to learn from the successful examples of other countries, including its Asian biotech competitors, according to a new report.

In India, government steps up efforts to develop more TB testing and treatment

December 3, 2019

By T.V. Padma

No Comments

HYDERABAD – India, home to a quarter of the global tuberculosis (TB) cases, plans to enhance its capacity to fight TB drug resistance and bolster susceptibility testing under a new initiative launched by the Geneva-based nonprofit Foundation for Innovative New Diagnostics (FIND).

ESMO Asia Congress 2019

Moving West to East: Panelists focus on Asia-prevalent cancers, NGS tests and precision oncology

November 26, 2019

By David Ho

No Comments

SINGAPORE – As the ESMO Asia Congress 2019 brought 3,679 participants from all over the Asia-Pacific region and beyond to Singapore’s Suntec Convention & Exhibition Centre, the focus, unsurprisingly, was on developments and challenges relevant to the oncology community.

Chinatrials12 Summit

With the help of trial experts, Chinese biotechs set sail for global market

November 13, 2019

By Elise Mak

No Comments

SHANGHAI – Innovation-driven biotech companies are sprouting up in China and they now aim to gain a bigger global presence through conducting clinical trials not just in their home country but also abroad.

GC Pharma, Vaxess partner on global commercialization of flu vaccine patch

October 30, 2019

By Jihyun Kim

No Comments

HONG KONG – One of South Korea's biggest pharmaceutical companies by market capitalization, GC Pharma Corp., based in Yong-in, Gyeonggi-do, and the Cambridge, Mass.-based U.S. biotech Vaxess Technologies Inc., have partnered to globally commercialize a flu vaccine patch based on Vaxess' Mimix Smart Release Patch technology.

Innocare seeks listing on HKEX to bring BTK inhibitor to market

October 23, 2019

By Elise Mak

No Comments

BEIJING – Cancer and autoimmune specialist Innocare Pharma Ltd., of Beijing, is seeking a pre-revenue listing on the Hong Kong Stock Exchange (HKEX) to raise capital to advance its BTK inhibitor, ICP-022, to an NDA filing in China by the end of this year.

Helixmith points to success in VM-202 phase III-Ib trial, though investors skeptical

October 23, 2019

By Jihyun Kim

No Comments

HONG KONG – South Korea's Helixmith Co. Ltd. has announced the results of a phase III trial extension testing VM-202 (donaperminogene seltoplasmid), a regenerative plasmid DNA gene therapy candidate, in diabetic peripheral neuropathy (DPN).

Newco News

Korea's Genome & Co. adds $25.2M in series C financing

October 23, 2019

By Jihyun Kim

No Comments

HONG KONG – South Korea's biopharmaceutical venture Genome & Co. Ltd. recently secured KRW30.2 billion (US$25.2 million) in series C investment with an IPO and global clinical trial plans for next year.

Asia-Pacific, BioWorld Asia
RSS

Rapt licenses FLX-475 to Hanmi in deal worth up to $118M

Celltrion’s Remsima SC wins marketing approval in EU

Indian pharma sector needs to learn from its competitors: report

In India, government steps up efforts to develop more TB testing and treatment

Moving West to East: Panelists focus on Asia-prevalent cancers, NGS tests and precision oncology

With the help of trial experts, Chinese biotechs set sail for global market

GC Pharma, Vaxess partner on global commercialization of flu vaccine patch

Innocare seeks listing on HKEX to bring BTK inhibitor to market

Helixmith points to success in VM-202 phase III-Ib trial, though investors skeptical

Korea's Genome & Co. adds $25.2M in series C financing

Popular Stories

Bioworld MedTech’s Oncology Extra

FDA gives thumbs up to Cochlear’s implantable bone conduction hearing system

Analysis by U.K. startup Medbelle highlights extent of drug pricing disparity

Buoyed by optimism and love of family, former FDA chief Frank Young leaned into storms

Biopharma companies continue their strong momentum in November

BioWorld Premium

Asia-Pacific, BioWorld Asia RSS

Popular Stories

BioWorld Premium

Asia-Pacific, BioWorld Asia
RSS